These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24576068)

  • 1. Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes.
    Valea I; Tinto H; Drabo MK; Huybregts L; Henry MC; Roberfroid D; Guiguemde RT; Kolsteren P; D'Alessandro U;
    Malar J; 2010 Nov; 9():324. PubMed ID: 24576068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.
    Gies S; Coulibaly SO; Ouattara FT; D'Alessandro U
    Trop Med Int Health; 2009 Feb; 14(2):174-82. PubMed ID: 19171009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso.
    Valea I; Tinto H; Drabo MK; Huybregts L; Sorgho H; Ouedraogo JB; Guiguemde RT; van Geertruyden JP; Kolsteren P; D'Alessandro U;
    Malar J; 2012 Mar; 11():71. PubMed ID: 22433778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region.
    Mikomangwa WP; Oms M; Aklillu E; Kamuhabwa AAR
    BMC Pregnancy Childbirth; 2019 Jul; 19(1):236. PubMed ID: 31286878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
    Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
    Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
    Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR
    Malar J; 2015 Feb; 14():69. PubMed ID: 25890159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon.
    Bouyou-Akotet MK; Mawili-Mboumba DP; Kendjo E; Moutandou Chiesa S; Tshibola Mbuyi ML; Tsoumbou-Bakana G; Zong J; Ambounda N; Kombila M
    Trans R Soc Trop Med Hyg; 2016 Jun; 110(6):333-42. PubMed ID: 27268713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi.
    Verhoeff FH; Brabin BJ; Chimsuku L; Kazembe P; Russell WB; Broadhead RL
    Ann Trop Med Parasitol; 1998 Mar; 92(2):141-50. PubMed ID: 9625909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact on pregnancy outcomes of intermittent preventive treatment with sulfadoxine-pyrimethamine in urban and peri-urban Papua New Guinea: a retrospective cohort study.
    Cellich P; Unger HW; Rogerson SJ; Mola GDL
    Malar J; 2024 Jul; 23(1):201. PubMed ID: 38970076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.
    Mosha D; Chilongola J; Ndeserua R; Mwingira F; Genton B
    Trop Med Int Health; 2014 Sep; 19(9):1048-56. PubMed ID: 24965022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.
    Sirima SB; Cotte AH; Konaté A; Moran AC; Asamoa K; Bougouma EC; Diarra A; Ouédraogo A; Parise ME; Newman RD
    Am J Trop Med Hyg; 2006 Aug; 75(2):205-11. PubMed ID: 16896120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysis.
    Chico RM; Cano J; Ariti C; Collier TJ; Chandramohan D; Roper C; Greenwood B
    Trop Med Int Health; 2015 Dec; 20(12):1621-33. PubMed ID: 26325263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent preventive treatment comparing two versus three doses of sulphadoxine pyrimethamine (IPTp-SP) in the prevention of anaemia in pregnancy in Ghana: A cross-sectional study.
    Agyeman YN; Newton S; Annor RB; Owusu-Dabo E
    PLoS One; 2021; 16(4):e0250350. PubMed ID: 33878140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy.
    Hommerich L; von Oertzen C; Bedu-Addo G; Holmberg V; Acquah PA; Eggelte TA; Bienzle U; Mockenhaupt FP
    Malar J; 2007 Nov; 6():144. PubMed ID: 17996048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effectiveness of two-dose
    Igboeli NU; Adibe MO; Ukwe CV; Aguwa CN
    J Vector Borne Dis; 2018; 55(3):197-202. PubMed ID: 30618445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
    Mushi V; Mbotwa CH; Zacharia A; Ambrose T; Moshi FV
    Malar J; 2021 Feb; 20(1):75. PubMed ID: 33549094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae.
    Mbaye A; Richardson K; Balajo B; Dunyo S; Shulman C; Milligan P; Greenwood B; Walraven G
    Trop Med Int Health; 2006 Jul; 11(7):992-1002. PubMed ID: 16827700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing the uptake of Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP) through seasonal malaria chemoprevention channel delivery: protocol of a multicenter cluster randomized implementation trial in Mali and Burkina Faso.
    Koita K; Bognini JD; Agboraw E; Dembélé M; Yabré S; Bihoun B; Coulibaly O; Niangaly H; N'Takpé JB; Lesosky M; Scaramuzzi D; Worrall E; Hill J; Briand V; Tinto H; Kayentao K
    BMC Public Health; 2024 Jan; 24(1):43. PubMed ID: 38166711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal.
    Olliaro PL; Delenne H; Cisse M; Badiane M; Olliaro A; Vaillant M; Brasseur P
    Malar J; 2008 Nov; 7():234. PubMed ID: 18992140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial.
    COSMIC Consortium
    Clin Infect Dis; 2019 Feb; 68(4):586-596. PubMed ID: 29961848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.